Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 24, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection in Cancer Validated by Cas9-Directed Nanopore Sequencing

Researchers used Cas9-directed Nanopore sequencing to validate structural variants detected by optical genome mapping in leukemia samples.
April 17, 2024 08:00 ET | Source: Bionano Genomics

Bionano and Diagens Sign Partnership to Commercialize the First Ever Clinical Cytogenetic Analysis that Combines OGM and Artificial Intelligence

Bionano and Diagens form strategic partnership to commercialize OGM plus AI cytogenetic analysis for reproductive health in China.
April 11, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication Showing that OGM Detects Over 1250 Structural Variants, including 56 Gene Fusions, in Pediatric Leukemia that were Missed by Whole Genome Sequencing

Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural variants.
April 04, 2024 13:44 ET | Source: Bionano Genomics

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 03, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication Showing that OGM Identifies Genetic Aberrations in Sarcoma Samples that May Lead to Improved Diagnosis but were Missed by Classical Cytogenetics

A peer-reviewed study compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples.
April 02, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces 9 Poster Presentations and Introduces New High Throughput Stratys™ System at the American Association for Cancer Research Annual Meeting

Bionano will unveil new genome analysis solutions for cancer research at the upcoming AACR annual conference in San Diego, California.
March 19, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Publication of a Breast Cancer Study Showing that the Number of SVs Detected with OGM May Be Related to Prognosis, Tumor Progression and Chemotherapy Resistance

SAN DIEGO, March 19, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study of optical genome mapping (OGM) in hereditary breast and ovarian cancer...
March 07, 2024 08:00 ET | Source: Bionano Genomics

Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) Annual Meeting Including Live Product Showcase Featuring the Company’s New Stratys™ System

Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical genome mapping (OGM) and findings from early...
March 05, 2024 16:01 ET | Source: Bionano Genomics

Bionano Reports Fourth Quarter and Full-Year 2023 Results and Provides Revenue Outlook for 2024

Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY 2022Reached installed base of 326 optical...
February 29, 2024 08:00 ET | Source: Bionano Genomics

Bionano to Present at TD Cowen’s 44th Annual Health Care Conference

SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at TD Cowen’s...